The Influence of Ursodeoxycholic Acid in Liver Functional Restoration in Obstructive Jaundice after Endoscopic Treatment

Table of Contents

1 BACKGROUND

1.1 Epidemiology

1.2 The diagnosis of obstructive jaundice

1.2.1 The clinical presentation

1.2.2 Laboratory findings

1.2.3 Imaging examination

1.2.3.1 Transabdominal sonography

1.2.3.2 Endoscopic sonography

1.2.3.3 Computed tomography

1.2.3.4 Magnetic Resonance Cholangiography (MRCP)

1.2.3.5 Endoscopic Retrograde Cholangiopancreatography (ERCP)

1.2.3.6 Percutaneous Transhepatic Cholangiopancreatography (PTC)

1.3 Differential diagnosis of jaundice

1.4 Obstructive jaundice- related complications

1.4.1 Intestinal permeability in obstructive jaundice

1.4.2 Hemostasis impairment in patients with obstructive jaundice

1.4.3 Obstructive jaundice and renal dysfunction

1.4.4 Obstructive jaundice and hepatic dysfunction

1.5 Treatment modalities

1.5.1 Endoscopic Retrograde Cholangiopancreatography (ERCP)

1.5.2 Surgical treatment

1.6 Ursodeoxycholic acid and its properties

1.6.1 Mechanisms of action of UDCA

1.6.1.1 Protection by UDCA against cell death induced by cytotoxic bile acids

1.6.1.2 Modulation of the expression of liver transporters and enzyme systems by UDCA

1.6.1.3 Modulation of cholangiocyte transport and ductular bile flow by UDCA

1.6.1.4 Immunosuppressive and anti-inflammatory properties of UDCA

2 AIMS AND PURPOSE OF THE RESEARCH

2.1 General aim

2.2 Specific aims

3 METHODS/DESIGN

3.1 Study objectives

3.2 Study design

3.2.1 ERCP procedure

3.2.2 Biochemical testing

3.2.3 Inclusion criteria

3.2.4 Exclusion criteria

3.2.5 UDCA administration

3.2.6 Power of the study

3.2.7 Data sources and search strategy

3.2.8 Outcomes

3.2.9 Randomization

3.2.10 Ethics

3.2.11 Data collection and statistical analysis

4 RESULTS

4.1 The effect of UDCA in relation to gender of patients

4.2 The effect of UDCA in relation to etiology of obstructive jaundice

4.3 The effect of UDCA in relation to age of patients

5 DISCUSSION

6 CONCLUSIONS

Research Objectives and Themes

This study aims to evaluate the efficacy of Ursodeoxycholic acid (UDCA) in restoring liver function in patients suffering from obstructive jaundice following endoscopic intervention. The research investigates how UDCA treatment impacts various biochemical markers across different patient demographics and etiologies.

• Liver functional restoration post-endoscopic treatment
• Clinical evaluation of UDCA administration
• Comparative analysis of obstructive jaundice etiologies
• Impact of gender and age on UDCA treatment response
• Biochemical marker trends including bilirubin, ALT, AST, GGT, and ALP

Excerpt from the Book

Summary of Chapters

1 BACKGROUND: Provides an overview of obstructive jaundice, its causes, complications, and the therapeutic potential of Ursodeoxycholic acid.

2 AIMS AND PURPOSE OF THE RESEARCH: Outlines the primary goal of assessing liver function recovery using UDCA and specifies short-term evaluation objectives.

3 METHODS/DESIGN: Details the prospective, randomized, controlled study methodology, including patient selection, ERCP procedure, and statistical analysis techniques.

4 RESULTS: Presents comprehensive data on biochemical changes in patients treated with UDCA, categorized by gender, etiology, and age.

5 DISCUSSION: Interprets the study findings, compares them with existing medical literature, and reflects on the clinical implications of UDCA therapy.

6 CONCLUSIONS: Summarizes the key findings, noting UDCA’s efficacy in accelerating the reduction of certain bilirubin and enzyme levels while highlighting variations based on jaundice etiology.

Keywords

obstructive jaundice, ursodeoxycholic acid, UDCA, endoscopic retrograde cholangiopancreatography, ERCP, liver function, bilirubin, alkaline phosphatase, GGT, ALT, AST, cholestasis, biliary obstruction, medical treatment

Frequently Asked Questions

What is the primary focus of this research?

The research focuses on evaluating the influence of Ursodeoxycholic acid (UDCA) on the recovery of liver function in patients who have undergone endoscopic treatment for obstructive jaundice.

What are the core research themes?

The core themes include the biochemical monitoring of patients with obstructive jaundice, the therapeutic role of UDCA, and how factors like age, gender, and the specific cause of the obstruction influence recovery.

What is the primary research question?

The research asks whether the administration of UDCA in the early post-endoscopic period significantly improves the rate of liver functional recovery compared to patients who do not receive the acid.

Which scientific method was applied?

The study employed a prospective, randomized, open-labeled, and controlled clinical trial design, involving 62 patients divided into an investigation group (UDCA) and a control group.

What topics are covered in the main body?

The main body covers the theoretical background of biliary obstruction, comprehensive diagnostic methodologies (ERCP, MRCP, CT), mechanisms of UDCA, detailed study design, and extensive data analysis of liver enzyme and bilirubin levels.

Which keywords best describe the study?

Key terms include obstructive jaundice, UDCA, ERCP, liver function, bilirubin, alkaline phosphatase, and cholestasis.

Does UDCA affect all patients equally regardless of the cause of jaundice?

No, the study concludes that UDCA is more effective in patients with choledocholithiasis than in those with malignant stenosis of the biliary tree.

Did patient age have a significant impact on the effectiveness of UDCA?

The study found that patient age had no significant impact on the overall effect of UDCA and did not modulate its performance.